Our data suggest that centrally located IPC may be used as natural fiducials for treatment positioning during IGRT for prostate cancer, with potential reductions in the risks and costs associated with fiducial implantation.
Department of Radiotherapy, Hospital Sírio-Libanês, São Paulo, SP, Brazil. samir.hanna [at] hsl.org.br
Int J Radiat Oncol Biol Phys. 2012 Mar;82(3):1208-16
© Galenicom 1999-2013